CHEBI:132975 - grazoprevir

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name grazoprevir
ChEBI ID CHEBI:132975
Definition An azamacrocyclic compound that is a hepatitis C protease inhibitor used in combination with elbasvir (under the brand name Zepatier) for treatment of chronic HCV genotypes 1 or 4 infection in adults.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Roles Classification
Biological Role(s): antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
hepatitis C protease inhibitor
An inhibitor of hepatitis C protease, an enzyme required for production of proteins needed for viral assembly.
Application(s): antiviral drug
A substance used in the prophylaxis or therapy of virus diseases.
hepatoprotective agent
Any compound that is able to prevent damage to the liver.
Related Structures
grazoprevir is a Structural Derivative of
carbamic acid
Mass : 61.04006
Formula : CH3NO2
28616 		quinoxaline
Mass : 130.14672
Formula : C8H6N2
36616 		naphthyridine
Mass : 130.147
Formula : C8H6N2
36624
Graph View Tree View
panning
Move up
Move left
Move down
Move right
Graph compression

Simplified view Show me the possible minimal nodes in this graph
Full view Show me all the nodes in this graph
Personalised view Create your own personalised ontology view, if you wish to remove any entity from your future visualisations please right click the entity (e.g. molecular entity)
My hidden entities
Edit
+Zoom in
-Zoom out
Download
Enter fullscreen